SpringWorks Therapeutics, Inc. (SWTX) Share-based Payment Arrangement, Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SpringWorks Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
  • SpringWorks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $30.5 M, a 30.2% increase year-over-year.
  • SpringWorks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $102 M, a 28.2% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $94.5 M, a 29.6% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $73 M, a 89.8% increase from 2021.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $38.4 M, a 283% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $102 M $30.5 M +$7.07 M +30.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $94.5 M $25.1 M +$6.14 M +32.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $88.4 M $23.1 M +$4.58 M +24.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $83.8 M $23 M +$4.55 M +24.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $79.3 M $23.4 M +$6.3 M +36.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $73 M $18.9 M +$7.04 M +59.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $65.9 M $18.5 M +$7.81 M +72.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $58.1 M $18.4 M +$9.63 M +110% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $48.5 M $17.1 M +$10 M +142% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $38.4 M $11.9 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $10.7 M +$7.67 M +252% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $8.8 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7.06 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $3.04 M +$2.26 M +286% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q3 2019 $788 K +$553 K +235% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q3 2018 $235 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.